Glucagon Market Size

Glucagon Market Size

Glucagon Market size was valued at around USD 422.6 million in 2023 and is estimated to grow at 5.9% CAGR from 2024 to 2032. Glucagon is a hormone produced by the pancreas that plays a crucial role in regulating blood sugar levels in the body. It acts in opposition to insulin - another pancreatic hormone, contributing to maintaining glucose homeostasis. In instances of low blood sugar levels, glucagon is released into the bloodstream, stimulating the liver.

This stimulation results in the conversion of stored glycogen into glucose, is then released into the bloodstream to raise blood sugar levels. This process known as glycogenolysis, is facilitated by glucagon. The increasing prevalence of diabetes serves as a substantial impetus for market growth. For instance, according to the National Institutes of Health (NIH), in 2021, an estimated 529 million individuals were affected with type 2 diabetes predominantly driving approximately 96% of diabetes cases globally. Thus, this underscores the significant demand for diabetes management and treatment solutions.
 

Furthermore, increasing research & development activities, growing demand for non-injectable emergency glycogen, advancements in pharmaceutical sector are the contributing factors stimulating the growth of the market.